Ftse Mib
35.090,23
-0,64%
DAX
20.214,79
-0,51%
S&P 500
5.827,04
-1,54%
NASDAQ
19.161,63
-1,63%
Bitcoin
94.314,08
-0,27%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ CNS Pharmaceuticals Inc (CNSP) CNS Pharmaceuticals Inc (CNSP) Notizie

CNS Pharmaceuticals Inc

CNSP
0,12
0,004 (3,45%)
11 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
11/12/202418:24EDGAR2Form 8-K - Current report
15/11/202422:19EDGAR2Form DEFR14A - Revised definitive proxy soliciting materials
14/11/202423:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202414:00EDGAR2Form 8-K - Current report
28/10/202421:15EDGAR2Form DEF 14A - Other definitive proxy statements
24/10/202423:27EDGAR2Form 8-K - Current report
24/10/202417:23EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
23/10/202414:02EDGAR2Form 8-K - Current report
15/10/202423:24EDGAR2Form PRE 14A - Other preliminary proxy statements
18/9/202422:30EDGAR2Form 8-K - Current report
12/9/202414:58EDGAR2Form 8-K - Current report
03/9/202414:00GLOBEIBN Announces Latest Episode of The BioMedWire Podcast..
14/8/202423:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202413:30EDGAR2Form 8-K - Current report
06/8/202423:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/8/202422:53EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/8/202422:11EDGAR2Form SC 13D - General Statement of Acquisition of Beneficial..
31/7/202418:32EDGAR2Form RW - Registration Withdrawal Request
30/7/202423:15EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
30/7/202423:13EDGAR2Form 8-K - Current report
30/7/202413:00EDGAR2Form 8-K - Current report
26/7/202414:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
26/7/202414:00EDGAR2Form 8-K - Current report
24/7/202415:30EDGAR2Form 8-K - Current report
19/7/202423:12EDGAR2Form S-1/A - General form for registration of securities..
12/7/202422:30EDGAR2Form S-1 - General form for registration of securities under..
09/7/202417:25EDGAR2Form 8-K - Current report
17/6/202417:17EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/6/202423:25EDGAR2Form 8-K - Current report
05/6/202423:00EDGAR2Form 8-K - Current report
16/5/202416:56EDGAR2Form 8-K - Current report
15/5/202423:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202423:28EDGAR2Form S-3 - Registration statement under Securities Act of..
07/5/202423:00EDGAR2Form 8-K - Current report
27/2/202423:15EDGAR2Form 8-K - Current report
21/2/202423:00EDGAR2Form 8-K - Current report
06/2/202416:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202416:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202416:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202423:00EDGAR2Form 8-K - Current report
31/1/202422:27EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
23/1/202422:01EDGAR2Form 8-K - Current report
22/1/202412:02EDGAR2Form S-1/A - General form for registration of securities..
Apertura: 0,1118 Min: 0,1044 Max: 0,1224
Chiusura: 0,116

La tua Cronologia

NASDAQ
CNSP
CNS Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network